{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:22:45Z","timestamp":1790076165785,"version":"4.0.1"},"reference-count":194,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T00:00:00Z","timestamp":1465516800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T00:00:00Z","timestamp":1465516800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1007\/s12016-016-8553-8","type":"journal-article","created":{"date-parts":[[2016,6,10]],"date-time":"2016-06-10T08:25:54Z","timestamp":1465547154000},"page":"121-139","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":45,"title":["The Story of Angioedema: from Quincke to Bradykinin"],"prefix":"10.1007","volume":"51","author":[{"given":"Avner","family":"Reshef","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mona","family":"Kidon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iris","family":"Leibovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2016,6,10]]},"reference":[{"key":"8553_CR1","unstructured":"Bible Hub. http:\/\/biblehub.com\/hebrew\/6638.htm. Accessed 5 Nov 2015"},{"key":"8553_CR2","unstructured":"Bible Hub. http:\/\/biblehub.com\/hebrew\/1216.htm. Accessed 5 Nov 2015"},{"key":"8553_CR3","volume-title":"A Greek\u2013English lexicon","author":"HG Liddell","year":"1940","unstructured":"Liddell HG, Scott R (1940) A Greek\u2013English lexicon. Clarendon, Oxford"},{"key":"8553_CR4","unstructured":"\u201cOn Medicine\u2014De medicina\u201d. World Digital Library. http:\/\/www.wdl.org\/en\/item\/11618\/. Accessed 4 Nov 2015"},{"key":"8553_CR5","unstructured":"http:\/\/penelope.uchicago.edu\/Thayer\/L\/Roman\/Texts\/Celsus\/3*.html. Accessed 28 Dec 2015"},{"issue":"1","key":"8553_CR6","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1111\/j.1365-4362.1989.tb01314.x","volume":"28","author":"BM Czarnetzki","year":"1989","unstructured":"Czarnetzki BM (1989) The history of urticaria. Int J Dermatol 28(1):52\u201357","journal-title":"Int J Dermatol"},{"key":"8553_CR7","volume-title":"Le Orticarie","author":"P Fabbri","year":"2005","unstructured":"Fabbri P (2005) Le Orticarie. UCB Pharma, Torino"},{"key":"8553_CR8","unstructured":"Zanca A (1964) Notizie sulla vita e sulle opere di Marcello Donati da Mantova. Medico, umanista, uomo di Stato. Casa Editrice Giardini, Pisa"},{"key":"8553_CR9","unstructured":"Mai, Franz Anton (1777, 1807) Stolpertus, ein junger Arzt am Krankenbette. Schwann & G\u00f6tz, Mannheim"},{"key":"8553_CR10","first-page":"376","volume":"69","author":"AF Barnett","year":"1948","unstructured":"Barnett AF (1948) Hereditary angioneurotic edema: a remarkable family history. Calif Med 69:376\u2013380","journal-title":"Calif Med"},{"key":"8553_CR11","unstructured":"Graves R (1843) Clinical lectures on the practice of medicine. In: Major MH (ed) Classic descriptions of disease, 3rd edn. Charles C. Thomas, Springfield, pp 623\u2013624"},{"key":"8553_CR12","first-page":"513","volume":"22","author":"JL Milton","year":"1876","unstructured":"Milton JL (1876) On giant urticaria. Edinb Med J 22:513\u2013526","journal-title":"Edinb Med J"},{"key":"8553_CR13","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1046\/j.1365-2230.2003.01178.x","volume":"28","author":"MM Black","year":"2003","unstructured":"Black MM (2003) The Neil Smith Memorial Lecture: John Laws Milton. The Founder of St John\u2019s Hospital for Diseases of the Skin. Clin Exp Dermatol 28:89\u201391","journal-title":"Clin Exp Dermatol"},{"key":"8553_CR14","first-page":"160","volume":"1","author":"H Quincke","year":"1882","unstructured":"Quincke H (1882) Uber akutes umschriebenes Hautoedem. Mschr Prakt Dermatol 1:160\u2013169","journal-title":"Mschr Prakt Dermatol"},{"key":"8553_CR15","first-page":"381","volume":"9","author":"P Str\u00fcbing","year":"1885","unstructured":"Str\u00fcbing P (1885) Uber acutes (angioneurotisches) Odem. Zeitschr F Klin Med 9:381","journal-title":"Zeitschr F Klin Med"},{"key":"8553_CR16","first-page":"257","volume":"15","author":"R Matas","year":"1887","unstructured":"Matas R (1887) Acute circumscribed oedema. New Orleans Med J 15:257","journal-title":"New Orleans Med J"},{"key":"8553_CR17","doi-asserted-by":"publisher","first-page":"362","DOI":"10.1097\/00000441-188804000-00004","volume":"95","author":"W Osler","year":"1888","unstructured":"Osler W (1888) Hereditary angio-neurotic oedema. Am J Med Sci 95:362","journal-title":"Am J Med Sci"},{"key":"8553_CR18","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/MAJ.0b013e3181b28028","volume":"339","author":"RD deShazo","year":"2010","unstructured":"deShazo RD, Frank MM (2010) Genius at work: Osler\u2019s 1888 article on hereditary angioedema. Am J Med Sci 339:179\u2013181","journal-title":"Am J Med Sci"},{"key":"8553_CR19","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1097\/00005053-189410000-00002","volume":"21","author":"HM Bannister","year":"1894","unstructured":"Bannister HM (1894) Acute angioneurotic oedema. J Nerv Ment Dis Chicago 21:627\u2013631","journal-title":"J Nerv Ment Dis Chicago"},{"key":"8553_CR20","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1097\/00000441-190405000-00016","volume":"127","author":"AW Fairbanks","year":"1904","unstructured":"Fairbanks AW (1904) Hereditary oedema. Am J Med Sci 127:877","journal-title":"Am J Med Sci"},{"key":"8553_CR21","first-page":"38","volume":"9","author":"W Bulloch","year":"1909","unstructured":"Bulloch W (1909) Angioneurotic oedema, the treasury of the human inheritance. Eugenics Lab Memoirs 9:38","journal-title":"Eugenics Lab Memoirs"},{"key":"8553_CR22","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1001\/archinte.1917.00090060014002","volume":"20","author":"JR Crowder","year":"1917","unstructured":"Crowder JR, Crowder TR (1917) Five generations of angioneurotic edema. Arch Int Med 20:840","journal-title":"Arch Int Med"},{"key":"8553_CR23","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1097\/00000441-192902000-00012","volume":"177","author":"HF Dunlap","year":"1929","unstructured":"Dunlap HF, Lemon WS (1929) The hereditary type of angioneurotic edema. Am J Med Sci 177:259\u2013273","journal-title":"Am J Med Sci"},{"key":"8553_CR24","unstructured":"Cockayne EA (1933) Inherited abnormalities of the skin and its appendages. Oxford University Press, Oxford, pp 371\u2013375"},{"key":"8553_CR25","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/S0021-9258(19)63283-7","volume":"236","author":"J Pensky","year":"1961","unstructured":"Pensky J, Levy LR, Lepow IH (1961) Partial purification of a serum inhibitor of C\u20191-esterase. J Biol Chem 236:1674\u20131679","journal-title":"J Biol Chem"},{"issue":"4","key":"8553_CR26","doi-asserted-by":"publisher","first-page":"316","DOI":"10.1016\/0021-8707(62)90031-X","volume":"33","author":"N Landerman","year":"1962","unstructured":"Landerman N (1962) Hereditary angioeneurotic edema: I. Case reports and review of the literature. J Allergy 33(4):316\u2013329","journal-title":"J Allergy"},{"key":"8553_CR27","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/0002-9343(63)90162-1","volume":"35","author":"VH Donaldson","year":"1963","unstructured":"Donaldson VH, Evans RR (1963) A biochemical abnormality in hereditary angioneurotic edema: absence of serum inhibitor of C\u20191-esterase. Am J Med 35:37\u201344","journal-title":"Am J Med"},{"issue":"11","key":"8553_CR28","doi-asserted-by":"publisher","first-page":"2204","DOI":"10.1172\/JCI105094","volume":"43","author":"VH Donaldson","year":"1964","unstructured":"Donaldson VH, Rosen FS (1964) Action of complement in hereditary angioneurotic edema: the role of C\u20191-esterase. J Clin Invest 43(11):2204\u20132213","journal-title":"J Clin Invest"},{"key":"8553_CR29","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1126\/science.148.3672.957","volume":"148","author":"FS Rosen","year":"1965","unstructured":"Rosen FS, Pensky J, Donaldson V, Charache P (1965) Hereditary angioneurotic edema: two genetic variants. Science 148:957\u2013958","journal-title":"Science"},{"key":"8553_CR30","doi-asserted-by":"publisher","first-page":"2143","DOI":"10.1172\/JCI106708","volume":"50","author":"FS Rosen","year":"1971","unstructured":"Rosen FS, Alper CA, Pensky J, Klemperer MR, Donaldson VH (1971) Genetically determined heterogeneity of the C1 esterase inhibitor in patients with hereditary angioneurotic edema. J Clin Invest 50:2143\u20132149","journal-title":"J Clin Invest"},{"key":"8553_CR31","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1542\/peds.37.6.1017","volume":"37","author":"VH Donaldson","year":"1966","unstructured":"Donaldson VH, Rosen FS (1966) Hereditary angioneurotic edema: a clinical survey. Pediatrics 37:1017\u20131027","journal-title":"Pediatrics"},{"key":"8553_CR32","doi-asserted-by":"publisher","first-page":"1356","DOI":"10.1056\/NEJM196906122802414","volume":"280","author":"FS Rosen","year":"1969","unstructured":"Rosen FS, Austen KF (1969) The neurotic edema (hereditary angioedema). N Engl J Med 280:1356\u20131357","journal-title":"N Engl J Med"},{"key":"8553_CR33","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1056\/NEJM197204132861510","volume":"286","author":"VH Donaldson","year":"1972","unstructured":"Donaldson VH (1972) Therapy of the neurotic edema. N Engl J Med 286:835\u2013836","journal-title":"N Engl J Med"},{"key":"8553_CR34","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/0090-1229(72)90006-2","volume":"1","author":"JR Caldwell","year":"1972","unstructured":"Caldwell JR, Ruddy S, Schur PH, Austen KF (1972) Acquired C1-inhibitor deficiency in lymphosarcoma. Clin Immunol Immunopathol 1:39\u201352","journal-title":"Clin Immunol Immunopathol"},{"key":"8553_CR35","doi-asserted-by":"publisher","first-page":"580","DOI":"10.7326\/0003-4819-84-5-580","volume":"84","author":"MM Frank","year":"1976","unstructured":"Frank MM, Gelfand JA, Atkinson JP (1976) Hereditary angioedema: the clinical syndrome and its management. Ann Intern Med 84:580\u2013593","journal-title":"Ann Intern Med"},{"key":"8553_CR36","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1016\/0091-6749(83)90052-0","volume":"72","author":"T Fields","year":"1983","unstructured":"Fields T, Ghebrehiwet B, Kaplan AP (1983) Kinin formation in hereditary angioedema plasma: evidence against kinin derivation from C2 and in support of \u201cspontaneous\u201d formation of bradykinin. J Allergy Clin Immunol 72:54\u201360","journal-title":"J Allergy Clin Immunol"},{"key":"8553_CR37","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1111\/j.1365-2249.1994.tb06009.x","volume":"95","author":"LR Shoemaker","year":"1994","unstructured":"Shoemaker LR, Schurman SJ, Donaldson VH, Davis AE III (1994) Hereditary angioneurotic oedema: characterization of plasma kinin and vascular permeability-enhancing activities. Clin Exp Immunol 95:22\u201328","journal-title":"Clin Exp Immunol"},{"key":"8553_CR38","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1056\/NEJM198502283120902","volume":"312","author":"RS Geha","year":"1985","unstructured":"Geha RS, Quinti I, Austen KF et al (1985) Acquired C1-inhibitor deficiency associated with antiidiotypic antibody to monoclonal immunoglobulins. N Engl J Med 312:534\u2013540","journal-title":"N Engl J Med"},{"key":"8553_CR39","doi-asserted-by":"publisher","first-page":"640","DOI":"10.1016\/0091-6749(85)90087-9","volume":"75","author":"AL Sheffer","year":"1985","unstructured":"Sheffer AL, Austen KF, Rosen FS, Fearon DT (1985) Acquired deficiency of the inhibitor of the first component of complement: report of five additional cases with commentary on the syndrome. J Allergy Clin Immunol 75:640\u2013646","journal-title":"J Allergy Clin Immunol"},{"key":"8553_CR40","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1056\/NEJM198705283162202","volume":"316","author":"J Alsenz","year":"1987","unstructured":"Alsenz J, Bork K, Loos M (1987) Autoantibody-mediated acquired deficiency of C1 inhibitor. N Engl J Med 316:1360\u20131366","journal-title":"N Engl J Med"},{"key":"8553_CR41","doi-asserted-by":"publisher","first-page":"489","DOI":"10.1016\/S0196-0644(84)80043-8","volume":"13","author":"GK Jett","year":"1984","unstructured":"Jett GK (1984) Captopril-induced angioedema. Ann Emerg Med 13:489\u2013490","journal-title":"Ann Emerg Med"},{"key":"8553_CR42","doi-asserted-by":"publisher","first-page":"234","DOI":"10.7326\/0003-4819-117-3-234","volume":"117","author":"ZH Israili","year":"1992","unstructured":"Israili ZH, Hall D (1992) Cough and angioneurotic edema associated with angiotensin converting-enzyme inhibitor therapy. Ann Int Med 117:234\u2013242","journal-title":"Ann Int Med"},{"key":"8553_CR43","doi-asserted-by":"publisher","first-page":"171","DOI":"10.2165\/00002018-199818030-00003","volume":"18","author":"W Vleeming","year":"1998","unstructured":"Vleeming W, Van Amsterdam JG, Sricker BH, de Wildt DJ (1998) ACE inhibitor-induced angioedema. Incidence, prevention and management. Drug Saf 18:171\u2013188","journal-title":"Drug Saf"},{"key":"8553_CR44","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1001\/jama.1988.03410070095035","volume":"260","author":"EE Slater","year":"1998","unstructured":"Slater EE, Merrill DD, Guess HA et al (1998) Clinical profile of angioedema associated with angiotensin converting enzyme inhibition. J Am Med Assoc 260:967\u2013970","journal-title":"J Am Med Assoc"},{"issue":"3","key":"8553_CR45","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1161\/HYPERTENSIONAHA.109.134197","volume":"54","author":"NJ Brown","year":"2009","unstructured":"Brown NJ, Byiers S, Carr D, Maldonado M, Warner BA (2009) Dipeptidyl peptidase IV inhibitor use associated with increased risk of ACE inhibitor-associated angioedema. Hypertension 54(3):516\u2013523","journal-title":"Hypertension"},{"key":"8553_CR46","doi-asserted-by":"publisher","first-page":"1693","DOI":"10.1016\/S0140-6736(97)09137-X","volume":"351","author":"J Nussberger","year":"1998","unstructured":"Nussberger J, Cugno M, Amstutz C, Cicardi M, Pellacani A, Agostoni A (1998) Plasma bradykinin in angio-oedema. Lancet 351:1693\u20131697","journal-title":"Lancet"},{"key":"8553_CR47","doi-asserted-by":"publisher","first-page":"213","DOI":"10.1016\/S0140-6736(00)02483-1","volume":"356","author":"K Bork","year":"2000","unstructured":"Bork K, Barnstedt S, Koch P, Traupe H (2000) Hereditary angioedema with normal C1-inhibitor activity in women. Lancet 356:213\u2013217","journal-title":"Lancet"},{"issue":"3","key":"8553_CR48","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1067\/mai.2000.108106","volume":"106","author":"K Binkley","year":"2000","unstructured":"Binkley K, Davis AE III (2000) Clinical, biochemical, and genetic characterization of a novel estrogen-dependent inherited form of angioedema. J Allergy Clin Immunol 106(3):546\u2013550","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"8553_CR49","doi-asserted-by":"publisher","first-page":"1098","DOI":"10.1086\/509899","volume":"79","author":"S Cichon","year":"2006","unstructured":"Cichon S, Martin L, Hennies H, Muller F, Van Driessche K et al (2006) Increased activity of coagulation factor XII (Hageman factor) causes hereditary angioedema type III. Am J Hum Genet 79(6):1098\u20131104","journal-title":"Am J Hum Genet"},{"issue":"4","key":"8553_CR50","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.1016\/j.bbrc.2006.03.092","volume":"343","author":"G Dewald","year":"2006","unstructured":"Dewald G, Bork K (2006) Missense mutations in the coagulation factor XII (Hageman factor) gene in hereditary angioedema with normal C1 inhibitor. Biochem Biophys Res Commun 343(4):1286\u20131289","journal-title":"Biochem Biophys Res Commun"},{"issue":"8","key":"8553_CR51","doi-asserted-by":"publisher","first-page":"1004","DOI":"10.1111\/all.12648","volume":"70","author":"K Bork","year":"2015","unstructured":"Bork K, Wulff K, Witzke G, Hardt J (2015) Hereditary angioedema with normal C1-INH with versus without specific FXII gene mutations. Allergy 70(8):1004\u20131012","journal-title":"Allergy"},{"issue":"8","key":"8553_CR52","doi-asserted-by":"publisher","first-page":"3132","DOI":"10.1172\/JCI77139","volume":"125","author":"J Bj\u00f6rkqvist","year":"2015","unstructured":"Bj\u00f6rkqvist J, de Maat S, Lewandrowski U, Di Gennaro A, Oschatz C et al (2015) Defective glycosylation of coagulation factor XII underlies hereditary angioedema type III. J Clin Invest 125(8):3132\u20133146","journal-title":"J Clin Invest"},{"key":"8553_CR53","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2015.07.041","author":"K Joseph","year":"2015","unstructured":"Joseph K, Tholanikunnel BG, Wolf B, Bork K, Kaplan AP (2015) Deficiency of plasminogen activator inhibitor 2 in plasma of patients with hereditary angioedema with normal C1 inhibitor levels. J Allergy Clin Immunol. doi:10.1016\/j.jaci.2015.07.041","journal-title":"J Allergy Clin Immunol"},{"key":"8553_CR54","first-page":"82","volume":"36","author":"DL Wilhelm","year":"1955","unstructured":"Wilhelm DL, Miles AA, Mackay ME (1955) Enzyme-like globulins from serum reproducing the vascular phenomena of inflammation. II. Isolation and properties of the permeability factor and its inhibitor. Br J Exp Pathol 36:82","journal-title":"Br J Exp Pathol"},{"key":"8553_CR55","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1038\/181096a0","volume":"181","author":"AA Miles","year":"1958","unstructured":"Miles AA, Wilhelm DW (1958) Distribution of globulin permeability factor and its inhibitor in the tissue fluid and lymph of the guinea pig. Nature 181:96","journal-title":"Nature"},{"key":"8553_CR56","first-page":"139","volume":"7","author":"NS Landerman","year":"1959","unstructured":"Landerman NS, Becker EL, Ratcliffe HE, Davis MJ, Kamin EJ (1959) Increased activity of the plasma permeability factor in familial hereditary angioedema. Clin Res 7:139","journal-title":"Clin Res"},{"key":"8553_CR57","doi-asserted-by":"publisher","first-page":"1053","DOI":"10.1016\/S0140-6736(60)90935-1","volume":"1","author":"NS Landerman","year":"1960","unstructured":"Landerman NS, Becker EL, Ratcliffe HE (1960) Increased cutaneous response to diluted autologous serum in hereditary angio-edema. Lancet 1:1053","journal-title":"Lancet"},{"key":"8553_CR58","doi-asserted-by":"crossref","first-page":"299","DOI":"10.4049\/jimmunol.84.3.299","volume":"84","author":"EL Becker","year":"1960","unstructured":"Becker EL (1960) Concerning the mechanism of complement action. V. The early steps in immune hemolysis. J Immunol 84:299\u2013308","journal-title":"J Immunol"},{"key":"8553_CR59","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4049\/jimmunol.92.3.456","volume":"92","author":"AL Haines","year":"1962","unstructured":"Haines AL, Lepow IH (1962) Studies on human C\u20191-esterase. I. Purification and enzymatic properties. J Immunol 92:456\u2013467","journal-title":"J Immunol"},{"issue":"4","key":"8553_CR60","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1016\/0021-8707(62)90032-1","volume":"33","author":"NS Landerman","year":"1962","unstructured":"Landerman NS, Webster ME, Becker EL, Ratcliffe HE (1962) Hereditary angioeneurotic edema: II. Deficiency of inhibitor from serum globulin permeability factor and\/or plasma kallikrein. J Allergy 33(4):330\u2013341","journal-title":"J Allergy"},{"key":"8553_CR61","first-page":"613","volume":"22","author":"LJ Kagen","year":"1963","unstructured":"Kagen LJ, Becker EL (1963) Inhibition of permeability globulins by C\u20191 esterase inhibitor. Fed Proc 22:613","journal-title":"Fed Proc"},{"key":"8553_CR62","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1084\/jem.118.5.681","volume":"118","author":"OD Ratnoff","year":"1963","unstructured":"Ratnoff OD, Lepow IH (1963) Complement as a mediator of inflammation. Enhancement of vascular permeability by purified human C\u20191 esterase. J Exp Med 118:681\u2013698","journal-title":"J Exp Med"},{"key":"8553_CR63","doi-asserted-by":"publisher","first-page":"546","DOI":"10.1016\/0021-8707(65)90192-9","volume":"36","author":"KL Burdon","year":"1965","unstructured":"Burdon KL, Queng JT, Thomas OC, McGovern JP (1965) Observations on biochemical abnormalities in hereditary angioneurotic edema. J Allergy 36:546\u2013557","journal-title":"J Allergy"},{"key":"8553_CR64","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1056\/NEJM196504012721301","volume":"272","author":"KF Austen","year":"1965","unstructured":"Austen KF, Sheffer AL (1965) Detection of hereditary angioneurotic edema by demonstration of a reduction in the second component of human complement. New Engl J Med 272:649\u2013656","journal-title":"New Engl J Med"},{"key":"8553_CR65","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1172\/JCI105756","volume":"47","author":"MR Klemperer","year":"1968","unstructured":"Klemperer MR, Donaldson VH, Rosen FS (1968) Effect of C\u20191 esterase on vascular permeability in man: studies in normal and complement-deficient individuals and in patients with hereditary angioneurotic edema. J Clin Invest 47:604\u2013611","journal-title":"J Clin Invest"},{"key":"8553_CR66","first-page":"45","volume":"48","author":"MR Klemperer","year":"1969","unstructured":"Klemperer MR, Rosen FS, Donaldson VH (1969) A polypeptide derived from the second component of human complement (C\u20192) which increases vascular permeability. J Clin Invest 48:45","journal-title":"J Clin Invest"},{"key":"8553_CR67","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1172\/JCI106022","volume":"48","author":"VH Donaldson","year":"1969","unstructured":"Donaldson VH, Ratnoff OD, da Silva WD, Rosen FS (1969) Permeability-increasing activity in hereditary angioneurotic edema plasma. II. Mechanism of formation and partial characterization. J Clin Invest 48:642\u2013653","journal-title":"J Clin Invest"},{"key":"8553_CR68","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1084\/jem.129.2.315","volume":"129","author":"OD Ratnoff","year":"1969","unstructured":"Ratnoff OD, Pensky J, Ogston D, Naff GB (1969) The inhibition of plasmin, plasma kallikrein, plasma permeability factor, and the C\u20191r subcomponent of the first component of complement by serum C\u20191 esterase inhibitor. J Exp Med 129:315\u2013331","journal-title":"J Exp Med"},{"key":"8553_CR69","first-page":"511","volume":"66","author":"J Abelous","year":"1909","unstructured":"Abelous J, Bardier E (1909) Les substances hypotensives de l\u2019urine humaine normale. CR Soc Biol 66:511\u2013512 (in French)","journal-title":"CR Soc Biol"},{"key":"8553_CR70","first-page":"663","volume":"142","author":"EK Frey","year":"1926","unstructured":"Frey EK (1926) Zusammenh\u00e4nge zwischen Herzarbeit und Nierent\u00e4tigkeit. Arch Klin Chir 142:663\u2013669 (in German)","journal-title":"Arch Klin Chir"},{"key":"8553_CR71","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1515\/bchm2.1930.192.1-3.1","volume":"192","author":"H Kraut","year":"1930","unstructured":"Kraut H, Frey EK, Werle E (1930) \u00dcber die Inaktivierung des Kallikreins. Hoppe-Seyler\u2019s Z Physiol Chem 192:1\u201321","journal-title":"Hoppe-Seyler\u2019s Z Physiol Chem"},{"key":"8553_CR72","first-page":"217","volume":"289","author":"E Werle","year":"1937","unstructured":"Werle E, G\u00f6tze W, Kappler A (1937) \u00dcber die Wirkung des Kallikreins auf den isolierten Darm und \u00fcber eine neue darmkontrahierende Substanz. Biochem Z 289:217\u2013233","journal-title":"Biochem Z"},{"key":"8553_CR73","volume-title":"Kallikrein (Padutin)","author":"EK Frey","year":"1950","unstructured":"Frey EK, Kraut H, Werle E (1950) Kallikrein (Padutin). Enke, Stuttgart"},{"issue":"4","key":"8553_CR74","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1172\/JCI103109","volume":"34","author":"OD Ratnoff","year":"1955","unstructured":"Ratnoff OD, Colopy JE (1955) A familial hemorrhagic trait associated with a deficiency of a clot promoting fraction of plasma. J Clin Invest 34(4):602\u2013613","journal-title":"J Clin Invest"},{"key":"8553_CR75","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1056\/NEJM196810032791407","volume":"279","author":"OD Ratnoff","year":"1968","unstructured":"Ratnoff OD (1968) The demise of John Hageman. N Engl J Med 279:760\u2013761","journal-title":"N Engl J Med"},{"issue":"4","key":"8553_CR76","doi-asserted-by":"publisher","first-page":"986","DOI":"10.1084\/jem.134.4.986","volume":"134","author":"CG Cochrane","year":"1971","unstructured":"Cochrane CG, Wuepper KD (1971) The first component of the kinin-forming system in human and rabbit plasma. Its relationship to clotting factor XII (Hageman factor). J Exp Med 134(4):986\u20131004","journal-title":"J Exp Med"},{"issue":"4","key":"8553_CR77","doi-asserted-by":"publisher","first-page":"696","DOI":"10.1084\/jem.133.4.696","volume":"133","author":"AP Kaplan","year":"1971","unstructured":"Kaplan AP, Austen KF (1971) A prealbumin activator of prekallikrein. II. Derivation of activators of prekallikrein from active Hageman factor by digestion with plasmin. J Exp Med 133(4):696\u2013712","journal-title":"J Exp Med"},{"issue":"3","key":"8553_CR78","doi-asserted-by":"crossref","first-page":"574","DOI":"10.4049\/jimmunol.104.3.574","volume":"104","author":"I Gigli","year":"1970","unstructured":"Gigli I, Mason JW, Colman RW, Austen KF (1970) Interaction of plasma kallikrein with the C1 inhibitor. J Immunol 104(3):574\u2013581","journal-title":"J Immunol"},{"issue":"11","key":"8553_CR79","doi-asserted-by":"publisher","first-page":"4179","DOI":"10.1073\/pnas.73.11.4179","volume":"73","author":"R Mandle","year":"1976","unstructured":"Mandle R, Colman R, Kaplan A (1976) Identification of prekallikrein and high molecular-weight kininogen as a complex in human plasma. Proc Natl Acad Sci U S A 73(11):4179\u20134183","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"8553_CR80","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1172\/JCI108754","volume":"60","author":"H Meier","year":"1977","unstructured":"Meier H, Pierce J, Colman R, Kaplan A (1977) Activation and function of human Hageman factor. The role of high molecular weight kininogen and prekallikrein. J Clin Invest 60(1):18\u201331","journal-title":"J Clin Invest"},{"key":"8553_CR81","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/BF00455384","volume":"262","author":"G Laurberg","year":"1978","unstructured":"Laurberg G (1978) Plasma kinin activation in tranexamic acid treated patients with hereditary angioneurotic edema. Arch Dermatol Res 262:153\u2013156","journal-title":"Arch Dermatol Res"},{"key":"8553_CR82","first-page":"174","volume":"90","author":"VH Donaldson","year":"1977","unstructured":"Donaldson VH, Rosen FS, Bing DH (1977) Role of the second component of complement (C2) and plasmin in kinin release in hereditary angioneurotic edema (H.A.N.E.) plasma. Trans Assoc Am Physicians 90:174\u2013183","journal-title":"Trans Assoc Am Physicians"},{"issue":"4","key":"8553_CR83","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1016\/j.jaci.2004.12.1132","volume":"115","author":"AP Kaplan","year":"2005","unstructured":"Kaplan AP, Ghebrehiwet B (2005) Does C-2 kinins exist? J Allergy Clin Immunol 115(4):876","journal-title":"J Allergy Clin Immunol"},{"key":"8553_CR84","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1084\/jem.20050664","volume":"202","author":"T Renn\u00e9","year":"2005","unstructured":"Renn\u00e9 T, Pozgajov\u00e1 M, Gr\u00fcner S et al (2005) Defective thrombus formation in mice lacking coagulation factor XII. J Exp Med 202:271\u2013281","journal-title":"J Exp Med"},{"key":"8553_CR85","first-page":"3208","volume":"118","author":"C Maas","year":"2008","unstructured":"Maas C, Govers-Riemslag JW, Bouma B et al (2008) Misfolded proteins activate factor XII in humans, leading to kallikrein formation without initiating coagulation. J Clin Invest 118:3208\u20133218","journal-title":"J Clin Invest"},{"key":"8553_CR86","doi-asserted-by":"publisher","first-page":"4296","DOI":"10.1182\/blood-2012-07-292094","volume":"120","author":"T Renn\u00e9","year":"2012","unstructured":"Renn\u00e9 T, Schmaier AH, Nickel KF, Blomb\u00e4ck M, Maas C (2012) In vivo roles of factor XII. Blood 120:4296\u20134303","journal-title":"Blood"},{"key":"8553_CR87","doi-asserted-by":"publisher","first-page":"1155","DOI":"10.1172\/JCI115416","volume":"88","author":"M Levi","year":"1991","unstructured":"Levi M, Hack CE, de Boer JP, Brandjes DP, Buller HR, ten Cate JW (1991) Reduction of contact activation related fibrinolytic activity in factor XII deficient patients. Further evidence for the role of the contact system in fibrinolysis in vivo. J Clin Invest 88:1155\u20131160","journal-title":"J Clin Invest"},{"key":"8553_CR88","first-page":"38","volume":"121","author":"M Cugno","year":"1993","unstructured":"Cugno M, Hack CE, de Boer JP, Eerenberg AJM, Agostoni A, Cicardi M (1993) Generation of plasmin during acute attacks of hereditary angioedema. J Lab Clin Med 121:38","journal-title":"J Lab Clin Med"},{"key":"8553_CR89","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1046\/j.1365-3083.1996.d01-298.x","volume":"44","author":"E Waage Nielsen","year":"1996","unstructured":"Waage Nielsen E, Johansen TH, H\u00f8gasen K, Wuillemin W, Hack CE, Mollnes TE (1996) Activation of the complement, coagulation, fibrinolytic and kallikrein\u2013kinin systems during attacks of hereditary angioedema. Scand J Immunol 44:185\u2013192","journal-title":"Scand J Immunol"},{"issue":"9","key":"8553_CR90","doi-asserted-by":"crossref","first-page":"3213","DOI":"10.1182\/blood.V89.9.3213","volume":"89","author":"M Cugno","year":"1997","unstructured":"Cugno M, Cicardi M, Bottasso B, Coppola R, Paonessa R, Mannucci PM, Agostoni A (1997) Activation of the coagulation cascade in C1-Inhibitor deficiencies. Blood 89(9):3213\u20133218","journal-title":"Blood"},{"key":"8553_CR91","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1161\/01.HYP.33.6.1431","volume":"33","author":"NJ Brown","year":"1999","unstructured":"Brown NJ, Gainer JV, Stein CM, Vaughan DE (1999) Bradykinin stimulates tissue plasminogen activator release in human vasculature. Hypertension 33:1431\u20131435","journal-title":"Hypertension"},{"key":"8553_CR92","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1016\/S1081-1206(10)60493-0","volume":"101","author":"K Joseph","year":"2008","unstructured":"Joseph K, Tuscano T, Kaplan A (2008) Studies of the mechanism of bradykinin formation in hereditary angioedema plasma. Ann Allergy Asthma Immunol 101:279\u2013286","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8553_CR93","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1111\/j.1398-9995.2008.01859.x","volume":"64","author":"M Cugno","year":"2009","unstructured":"Cugno M, Zanichelli A, Bellatorre AG, Griffini S, Cicardi M (2009) Plasma biomarkers of acute attacks in patients with angioedema due to C1-inhibitor deficiency. Allergy 64:254\u2013257","journal-title":"Allergy"},{"key":"8553_CR94","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1111\/j.1365-2249.2011.04541.x","volume":"167","author":"M van Geffen","year":"2012","unstructured":"van Geffen M, Cugno M, Lap P, Loof A, Cicardi M, van Heerde W (2012) Alterations of coagulation and fibrinolysis in patients with angioedema due to C1-inhibitor deficiency. Clin Exp Immunol 167:472\u2013478","journal-title":"Clin Exp Immunol"},{"key":"8553_CR95","doi-asserted-by":"publisher","first-page":"43","DOI":"10.2165\/11599490-000000000-00000","volume":"26","author":"A Relan","year":"2012","unstructured":"Relan A, Bakhtiari K, van Amersfoort ES, Meijers JCM, Hack CE (2012) Recombinant C1-inhibitor: effects on coagulation and fibrinolysis in patients with hereditary angioedema. BioDrugs 26:43\u201352","journal-title":"BioDrugs"},{"key":"8553_CR96","doi-asserted-by":"publisher","first-page":"506","DOI":"10.1111\/all.12587","volume":"70","author":"A Reshef","year":"2015","unstructured":"Reshef A, Zanichelli A, Longhurst H, Relan A, Hack CE (2015) Elevated D-dimers in attacks of hereditary angioedema are not associated with increased thrombotic risk. Allergy 70:506\u2013513","journal-title":"Allergy"},{"key":"8553_CR97","doi-asserted-by":"publisher","first-page":"1050","DOI":"10.1056\/NEJM198305053081802","volume":"308","author":"M Schapira","year":"1983","unstructured":"Schapira M, Silver LD, Scott CF, Schmaier AH, Prograis LJ Jr et al (1983) Prekallikrein activation and high-molecular-weight kininogen consumption in hereditary angioedema. N Engl J Med 308:1050\u20131053","journal-title":"N Engl J Med"},{"issue":"3","key":"8553_CR98","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1172\/JCI110656","volume":"70","author":"JT Dunn","year":"1982","unstructured":"Dunn JT, Kaplan AP (1982) Formation and structure of human Hageman factor fragments. J Clin Invest 70(3):627\u2013631","journal-title":"J Clin Invest"},{"key":"8553_CR99","doi-asserted-by":"publisher","first-page":"1450","DOI":"10.1172\/JCI110898","volume":"71","author":"B Ghebrehiwet","year":"1983","unstructured":"Ghebrehiwet B, Randazzo BP, Dunn JT, Silverberg M, Kaplan AP (1983) Mechanisms of activation of the classical pathway of complement by Hageman factor fragment. J Clin Invest 71:1450\u20131456","journal-title":"J Clin Invest"},{"issue":"6","key":"8553_CR100","doi-asserted-by":"publisher","first-page":"1542","DOI":"10.1172\/JCI111360","volume":"73","author":"A de Agostini","year":"1984","unstructured":"de Agostini A, Lijnen HR, Pixley RA, Colman RW, Schapira M (1984) Inactivation of factor XII active fragment in normal plasma. Predominant role of C-1-inhibitor. J Clin Invest 73(6):1542\u20131549","journal-title":"J Clin Invest"},{"issue":"1\u20132","key":"8553_CR101","first-page":"53","volume":"15","author":"CL Cameron","year":"1989","unstructured":"Cameron CL, Fisslthaler B, Sherman A, Reddigari S, Silverberg M (1989) Studies on contact activation: effects of surface and inhibitors. Med Prog Thr Technol 15(1\u20132):53\u201362","journal-title":"Med Prog Thr Technol"},{"issue":"3","key":"8553_CR102","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/S1567-5769(02)00162-5","volume":"3","author":"M Cugno","year":"2003","unstructured":"Cugno M, Nussberger J, Cicardi M, Agostoni A (2003) Bradykinin and the pathophysiology of angioedema. Int Immunopharmacol 3(3):311\u2013317","journal-title":"Int Immunopharmacol"},{"issue":"2","key":"8553_CR103","doi-asserted-by":"publisher","first-page":"470","DOI":"10.1016\/j.jaci.2013.03.026","volume":"132","author":"K Joseph","year":"2013","unstructured":"Joseph K, Kaplan AP (2013) Factor XII independent activation of the bradykinin forming cascade: implications for the pathogenesis of hereditary angioedema types I and II. J Allergy Clin Immunol 132(2):470\u2013475","journal-title":"J Allergy Clin Immunol"},{"key":"8553_CR104","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1016\/S0091-6749(99)70030-8","volume":"104","author":"J Nussberger","year":"1999","unstructured":"Nussberger J, Cugno M, Cicardi M, Agostoni A (1999) Local bradykinin generation in hereditary angioedema. J Allergy Clin Immunol 104:1321\u20131322","journal-title":"J Allergy Clin Immunol"},{"key":"8553_CR105","doi-asserted-by":"publisher","first-page":"1057","DOI":"10.1172\/JCI200214211","volume":"109","author":"ED Han","year":"2002","unstructured":"Han ED, MacFarlane RC, Mulligan AN et al (2002) Increased vascular permeability in C1 inhibitor-deficient mice mediated by the bradykinin type 2 receptor. J Clin Invest 109:1057\u20131063","journal-title":"J Clin Invest"},{"issue":"6","key":"8553_CR106","doi-asserted-by":"publisher","first-page":"1303","DOI":"10.1016\/j.jaci.2009.08.007","volume":"124","author":"F Bossi","year":"2009","unstructured":"Bossi F, Fischetti F, Regoli D, Durigutto P, Frossi B, Gobeil F Jr et al (2009) Novel pathogenic mechanism and therapeutic approaches to angioedema associated with C1 inhibitor deficiency. J Allergy Clin Immunol 124(6):1303\u20131310","journal-title":"J Allergy Clin Immunol"},{"key":"8553_CR107","doi-asserted-by":"publisher","first-page":"608","DOI":"10.3181\/00379727-101-25034","volume":"101","author":"LR Levy","year":"1959","unstructured":"Levy LR, Lepow IH (1959) Assay and properties of serum inhibitor of C\u20191 esterase. Proc Soc Exp Biol (NY) 101:608\u2013611","journal-title":"Proc Soc Exp Biol (NY)"},{"key":"8553_CR108","doi-asserted-by":"publisher","first-page":"4292","DOI":"10.1021\/bi00363a018","volume":"25","author":"SC Bock","year":"1986","unstructured":"Bock SC, Skriver K, Nielsen E, Th\u00f9gersen H-C, Wiman B, Donaldson VH et al (1986) Human C1 inhibitor: primary structure, cDNA cloning, and chromosomal localization. Biochemistry 25:4292\u20134301","journal-title":"Biochemistry"},{"key":"8553_CR109","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.1073\/pnas.83.10.3161","volume":"83","author":"AE Davis 3rd","year":"1986","unstructured":"Davis AE 3rd, Whitehead AS, Harrison RA, Dauphinais A, Bruns GA, Cicardi M et al (1986) Human inhibitor of the first component of complement, C1: characterization of cDNA clones and localization of the gene to chromosome 11. Proc Natl Acad Sci U S A 83:3161\u20133165","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8553_CR110","doi-asserted-by":"crossref","first-page":"3066","DOI":"10.1016\/S0021-9258(18)94031-7","volume":"264","author":"K Skriver","year":"1989","unstructured":"Skriver K, Radziejewska E, Silbermann JA, Donaldson VH, Bock SC (1989) CpG mutations in the reactive site of human C1 inhibitor. J Biol Chem 264:3066\u20133071","journal-title":"J Biol Chem"},{"key":"8553_CR111","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1007\/BF00195824","volume":"84","author":"A Theriault","year":"1990","unstructured":"Theriault A, Whaley K, McPhaden AR, Boyd E, Connor JM (1990) Regional assignment of the human C1-inhibitor gene to 11q11-q13.1. Hum Genet 84:477\u2013479","journal-title":"Hum Genet"},{"key":"8553_CR112","doi-asserted-by":"publisher","first-page":"10609","DOI":"10.1073\/pnas.88.23.10609","volume":"88","author":"M Janson","year":"1991","unstructured":"Janson M, Larsson C, Werelius B, Jones C, Glaser T, Nakamura Y et al (1991) Detailed physical map of human chromosomal region 11q12-13 shows high meiotic recombination rate around the MEN1 locus. Proc Natl Acad Sci U S A 88:10609\u201310613","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8553_CR113","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1073\/pnas.87.4.1551","volume":"87","author":"D Stoppa-Lyonnet","year":"1990","unstructured":"Stoppa-Lyonnet D, Carter PE, Meo T, Tosi M (1990) Clusters of intragenic Alu repeats predispose the human C1 inhibitor locus to deleterious rearrangements. Proc Natl Acad Sci U S A 87:1551\u20131555","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8553_CR114","doi-asserted-by":"publisher","first-page":"301","DOI":"10.1111\/j.1432-1033.1991.tb15911.x","volume":"197","author":"PE Carter","year":"1991","unstructured":"Carter PE, Duponchel C, Tosi M, Fothergill JE (1991) Complete nucleotide sequence of the gene for human C1 inhibitor with an unusually high density of Alu elements. Eur J Biochem 197:301\u2013308","journal-title":"Eur J Biochem"},{"key":"8553_CR115","doi-asserted-by":"publisher","first-page":"358","DOI":"10.1016\/S0171-2985(98)80040-5","volume":"199","author":"M Tosi","year":"1998","unstructured":"Tosi M (1998) Molecular genetics of C-inhibitor. Immunobiology 199:358\u2013365","journal-title":"Immunobiology"},{"key":"8553_CR116","unstructured":"HGMD database. http:\/\/www.biobase-international.com\/product\/hgmd. Accessed May 2015"},{"key":"8553_CR117","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00439-013-1358-4","volume":"133","author":"PD Stenson","year":"2014","unstructured":"Stenson PD, Mort M, Ball EV, Shaw K, Phillips A, Cooper DN (2014) The Human Gene Mutation Database: building a comprehensive mutation repository for clinical and molecular genetics, diagnostic testing and personalized genomic medicine. Hum Genet 133:1\u20139","journal-title":"Hum Genet"},{"key":"8553_CR118","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/humu.20112","volume":"25","author":"L Kalm\u00e1r","year":"2005","unstructured":"Kalm\u00e1r L, Heged\u00fcs T, Farkas H, Nagy M, Tordai A (2005) HAEdb: a novel interactive, locus-specific mutation database for the C1 inhibitor gene. Hum Mutat 25:1\u20135 (http:\/\/hae.enzim.hu\/. Accessed 25 Dec 2015)","journal-title":"Hum Mutat"},{"key":"8553_CR119","doi-asserted-by":"publisher","first-page":"658","DOI":"10.1016\/j.rbmo.2010.05.016","volume":"21","author":"R Bautista-Ll\u00e1cer","year":"2010","unstructured":"Bautista-Ll\u00e1cer R, Alberola TM, Vendrell X, Fern\u00e1ndez E, P\u00e9rez-Alonso M (2010) Case report: first successful application of preimplantation genetic diagnosis for hereditary angiooedema. Reprod Biomed Online 21:658\u2013662","journal-title":"Reprod Biomed Online"},{"key":"8553_CR120","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1080\/00015550152572985","volume":"81","author":"H Farkas","year":"2001","unstructured":"Farkas H, Harmat G, Fay A et al (2001) Erythema marginatum preceding an oedematous attack of hereditary angioneurotic oedema. Acta Derm Venereol 81:376\u2013377","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"8553_CR121","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1097\/01.SMJ.0000140850.22535.FA","volume":"97","author":"JC Starr","year":"2004","unstructured":"Starr JC, Brasher GW, Rao A, Posey D (2004) Erythema marginatum and hereditary angioedema. South Med J 97(1):948\u2013950","journal-title":"South Med J"},{"key":"8553_CR122","doi-asserted-by":"publisher","first-page":"493","DOI":"10.2500\/aap.2009.30.3278","volume":"30","author":"JG Kemp","year":"2009","unstructured":"Kemp JG, Craig TJ (2009) Variability of prodromal signs and symptoms associated with hereditary angioedema attacks: a literature review. Allergy Asthma Proc 30:493\u2013499","journal-title":"Allergy Asthma Proc"},{"key":"8553_CR123","doi-asserted-by":"publisher","first-page":"506","DOI":"10.2500\/aap.2009.30.3279","volume":"30","author":"MJ Prematta","year":"2009","unstructured":"Prematta MJ, Kemp JG, Gibbs JG, Craig TJ (2009) Frequency, timing, and type of prodromal symptoms associated with hereditary angioedema attacks. Allergy Asthma Proc 30:506\u2013511","journal-title":"Allergy Asthma Proc"},{"issue":"3","key":"8553_CR124","doi-asserted-by":"publisher","first-page":"261","DOI":"10.2500\/aap.2013.34.3663","volume":"34","author":"A Reshef","year":"2013","unstructured":"Reshef A, Prematta M, Craig TJ (2013) Signs and symptoms preceding acute attacks of hereditary angioedema: results of three recent surveys. Allergy Asthma Proc 34(3):261\u2013266","journal-title":"Allergy Asthma Proc"},{"issue":"4","key":"8553_CR125","doi-asserted-by":"publisher","first-page":"739","DOI":"10.7326\/0003-4819-53-4-739","volume":"53","author":"WB Spaulding","year":"1960","unstructured":"Spaulding WB (1960) Methyl-testosterone therapy for hereditary episodic edema (hereditary angioneurotic edema). Ann Intern Med 53(4):739\u2013745","journal-title":"Ann Intern Med"},{"key":"8553_CR126","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1056\/NEJM197612232952602","volume":"295","author":"JA Gelfand","year":"1976","unstructured":"Gelfand JA, Sherins RJ, Alling DW, Frank MM (1976) Treatment of hereditary angioedema with danazol. Reversal of clinical and biochemical abnormalities. N Engl J Med 295:1444\u20131448","journal-title":"N Engl J Med"},{"key":"8553_CR127","first-page":"348","volume":"42","author":"JP Atkinson","year":"1979","unstructured":"Atkinson JP (1979) Diagnosis and management of hereditary angioedema (HAE). Ann Allergy 42:348\u2013352","journal-title":"Ann Allergy"},{"key":"8553_CR128","doi-asserted-by":"publisher","first-page":"370","DOI":"10.2165\/00003495-198019050-00007","volume":"19","author":"SW Hosea","year":"1980","unstructured":"Hosea SW, Frank MM (1980) Danazol in the treatment of hereditary angioedema. Drugs 19:370\u2013372","journal-title":"Drugs"},{"key":"8553_CR129","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/0091-6749(80)90181-5","volume":"65","author":"A Agostoni","year":"1980","unstructured":"Agostoni A, Cicardi M, Martignoni GC, Bergamaschini L, Marasini B (1980) Danazol and stanozolol in long-term prophylactic treatment of hereditary angioedema. J Allergy Clin Immunol 65:75\u201379","journal-title":"J Allergy Clin Immunol"},{"key":"8553_CR130","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1016\/S0091-6749(97)70095-2","volume":"99","author":"M Cicardi","year":"1997","unstructured":"Cicardi M, Castelli R, Zingale LC, Agostoni A (1997) Side effects of long-term prophylaxis with attenuated androgens in hereditary angioedema: comparison of treated and untreated patients. J Allergy Clin Immunol 99:194\u2013196","journal-title":"J Allergy Clin Immunol"},{"key":"8553_CR131","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1089\/pai.1999.13.189","volume":"13","author":"AJ Barakat","year":"1999","unstructured":"Barakat AJ, Castaldo AJ (1999) Successful use of Oxandrolone in the prophylaxis of hereditary angioedema: a case report. Pediatr Asthma Allergy Immunol 13:189\u2013193","journal-title":"Pediatr Asthma Allergy Immunol"},{"key":"8553_CR132","doi-asserted-by":"publisher","first-page":"105","DOI":"10.2302\/kjm.11.105","volume":"11","author":"S Okamoto","year":"1962","unstructured":"Okamoto S, Okamoto U (1962) Amino-methyl-cyclohexane-carboxylic acid: AMCHA. A new potent inhibitor of fibrinolysis. Keio J Med 11:105\u2013115","journal-title":"Keio J Med"},{"key":"8553_CR133","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3109\/ort.1966.37.suppl-91.01","volume":"448","author":"IM Nillson","year":"1966","unstructured":"Nillson IM, Andersson L, Bjorkman SE (1966) Epsilon-aminocaproic acid (E-ACA) as a therapeutic agent based on 5 year\u2019s clinical experience. Acta Med Scand Suppl 448:1\u201346","journal-title":"Acta Med Scand Suppl"},{"key":"8553_CR134","first-page":"733","volume":"3","author":"B Lundh","year":"1968","unstructured":"Lundh B, Laurell AB, Wetterqvist H, White T, Granerus G (1968) A case of hereditary angioneurotic oedema, successfully treated with e-aminocaproic acid. Studies on C\u20191 esterase inhibitor, C\u20191 activation, plasminogen level and histamine metabolism. Clin Exp Immunol 3:733\u2013745","journal-title":"Clin Exp Immunol"},{"key":"8553_CR135","doi-asserted-by":"publisher","first-page":"452","DOI":"10.1056\/NEJM197208312870907","volume":"287","author":"AL Sheffer","year":"1972","unstructured":"Sheffer AL, Austen KF, Rosen FS (1972) Tranexamic acid therapy in hereditary angioneurotic edema. N Engl J Med 287:452\u2013454","journal-title":"N Engl J Med"},{"key":"8553_CR136","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1056\/NEJM197204132861503","volume":"286","author":"MM Frank","year":"1972","unstructured":"Frank MM, Sergent JS, Kane MA, Alling DW (1972) Epsilon aminocaproic acid therapy of hereditary angioneurotic edema. A double-blind study. N Engl J Med 286:808\u2013812","journal-title":"N Engl J Med"},{"key":"8553_CR137","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1111\/j.0954-6820.1972.tb04818.x","volume":"192","author":"G Blohme","year":"1972","unstructured":"Blohme G (1972) Treatment of hereditary angioneurotic oedema with tranexamic acid. A random double-blind cross-over study. Acta Med Scand 192:293\u2013298","journal-title":"Acta Med Scand"},{"key":"8553_CR138","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1016\/0091-6749(77)90080-X","volume":"60","author":"AL Sheffer","year":"1977","unstructured":"Sheffer AL, Fearon DT, Austen KF, Rosen FS (1977) Tranexamic acid: preoperative prophylactic therapy for patients with hereditary angioneurotic edema. J Allergy Clin Immunol 60:38\u201340","journal-title":"J Allergy Clin Immunol"},{"issue":"7590","key":"8553_CR139","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1016\/S0140-6736(69)91295-1","volume":"1","author":"RJ Pickering","year":"1969","unstructured":"Pickering RJ, Good RA, Kelly JR, Gewurz H (1969) Replacement therapy in hereditary angioedema. Successful treatment of two patients with fresh frozen plasma. Lancet 1(7590):326\u2013330","journal-title":"Lancet"},{"issue":"12","key":"8553_CR140","first-page":"690","volume":"30","author":"G Cohen","year":"1972","unstructured":"Cohen G, Peterson A (1972) Treatment of hereditary angioedema with frozen plasma. Ann Allergy 30(12):690\u2013692","journal-title":"Ann Allergy"},{"issue":"12","key":"8553_CR141","doi-asserted-by":"publisher","first-page":"620","DOI":"10.1007\/BF01468576","volume":"51","author":"D Brackertz","year":"1973","unstructured":"Brackertz D, Kueppers F (1973) Possible therapy in hereditary angioneurotic edema (HAE). Klin Wochenschr 51(12):620\u2013622","journal-title":"Klin Wochenschr"},{"issue":"7830","key":"8553_CR142","doi-asserted-by":"publisher","first-page":"680","DOI":"10.1016\/S0140-6736(73)92519-1","volume":"2","author":"D Brackertz","year":"1973","unstructured":"Brackertz D, Kueppers F (1973) Hereditary angioneurotic oedema. Lancet 2(7830):680","journal-title":"Lancet"},{"key":"8553_CR143","doi-asserted-by":"publisher","first-page":"1630","DOI":"10.1056\/NEJM199606203342503","volume":"334","author":"AT Waytes","year":"1996","unstructured":"Waytes AT, Rosen FS, Frank MM (1996) Treatment of hereditary angioedema with a vapor-heated C1 inhibitor concentrate. N Engl J Med 334:1630\u20131634","journal-title":"N Engl J Med"},{"key":"8553_CR144","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1046\/j.1537-2995.1998.38698326333.x","volume":"38","author":"M Kunschak","year":"1998","unstructured":"Kunschak M, Engl W, Maritsch F, Rosen FS, Eder G, Zerlauth G (1998) A randomized, controlled trial to study the efficacy and safety of C1-INH concentrate in treating hereditary angioedema. Transfusion 38:540\u2013549","journal-title":"Transfusion"},{"key":"8553_CR145","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.jaci.2009.07.017","volume":"124","author":"TJ Craig","year":"2009","unstructured":"Craig TJ, Levy RJ, Wasserman RL, Bewtra AK, Hurewitz D, Obtulowicz K, Reshef A et al (2009) Efficacy of human C1 esterase inhibitor concentrate compared with placebo in acute hereditary angioedema attacks. J Allergy Clin Immunol 124:801\u2013808","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8553_CR146","doi-asserted-by":"publisher","first-page":"280","DOI":"10.1016\/j.clim.2011.11.005","volume":"142","author":"JJ Hofstra","year":"2012","unstructured":"Hofstra JJ, Kleine Budde I, van Twuyver E et al (2012) Treatment of hereditary angioedema with nanofiltered C1-esterase inhibitor concentrate (Cetor\u00ae): multi-center phase II and III studies to assess pharmacokinetics, clinical efficacy and safety. Clin Immunol 142(3):280\u2013290","journal-title":"Clin Immunol"},{"issue":"6","key":"8553_CR147","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1056\/NEJMoa0805538","volume":"363","author":"BL Zuraw","year":"2010","unstructured":"Zuraw BL, Busse PJ, White M et al (2010) Nanofiltered C1 inhibitor concentrate for treatment of hereditary angioedema. N Engl J Med 363(6):513\u2013522","journal-title":"N Engl J Med"},{"issue":"1","key":"8553_CR148","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1093\/glycob\/cwh010","volume":"14","author":"K Koles","year":"2004","unstructured":"Koles K, van Berkel PHC, Pieper FR, Nuijens JH, Mannesse MLM et al (2004) N- and O-glycans of recombinant human C1 inhibitor expressed in the milk of transgenic rabbits. Glycobiology 14(1):51\u201364","journal-title":"Glycobiology"},{"key":"8553_CR149","doi-asserted-by":"publisher","first-page":"821","DOI":"10.1016\/j.jaci.2010.07.021","volume":"126","author":"B Zuraw","year":"2010","unstructured":"Zuraw B, Cicardi M, Levy RJ, Nuijens JH, Relan A et al (2010) Recombinant human C1-inhibitor for the treatment of acute angioedema attacks in patients with hereditary angioedema. J Allergy Clin Immunol 126:821\u2013827","journal-title":"J Allergy Clin Immunol"},{"key":"8553_CR150","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2340\/00015555493744","volume":"49","author":"L Juhlin","year":"1969","unstructured":"Juhlin L, Michaelsson G (1969) Use of a kallikrein inhibitor in the treatment of urticaria and hereditary angioneurotic edema. Acta Derm Venereol 49:37\u201344","journal-title":"Acta Derm Venereol"},{"key":"8553_CR151","doi-asserted-by":"publisher","first-page":"S231","DOI":"10.1016\/j.jaci.2007.12.1190","volume":"121","author":"R Levy","year":"2008","unstructured":"Levy R, McNeil D, Li H, Hsu FL, Horn P, Roberts J (2008) Results of a 2-stage, phase 3 pivotal trial EDEMA3: a study of subcutaneous DX-88 (ecallantide), a plasma kallikrein inhibitor, in patients with hereditary angioedema (HAE). J Allergy Clin Immunol 121:S231","journal-title":"J Allergy Clin Immunol"},{"key":"8553_CR152","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1056\/NEJMoa0905079","volume":"363","author":"M Cicardi","year":"2010","unstructured":"Cicardi M, Levy RJ, McNeil DL et al (2010) Ecallantide for the treatment of acute attacks in hereditary angioedema. N Engl J Med 363:523\u2013531","journal-title":"N Engl J Med"},{"key":"8553_CR153","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1016\/j.anai.2010.04.012","volume":"104","author":"RJ Levy","year":"2010","unstructured":"Levy RJ, Lumry WR, McNeil DL et al (2010) EDEMA4: a phase 3, double-blind study of subcutaneous ecallantide treatment for acute attacks of hereditary angioedema. Ann Allergy Asthma Immunol 104:523\u2013529","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8553_CR154","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jaci.2011.03.006","volume":"128","author":"AL Sheffer","year":"2011","unstructured":"Sheffer AL, Campion M, Levy RJ, Li HH, Horn PT, Pullman WE (2011) Ecallantide (DX-88) for acute hereditary angioedema attacks: integrated analysis of 2 double-blind, phase 3 studies. J Allergy Clin Immunol 128:153\u2013159","journal-title":"J Allergy Clin Immunol"},{"key":"8553_CR155","doi-asserted-by":"publisher","first-page":"769","DOI":"10.1111\/j.1476-5381.1991.tb12248.x","volume":"102","author":"FJ Hock","year":"1991","unstructured":"Hock FJ, Wirth K, Albus U, Linz W, Gerhards HJ, Wiemer G, Henke S et al (1991) Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies. Br J Pharmacol 102:769\u2013773","journal-title":"Br J Pharmacol"},{"key":"8553_CR156","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1016\/0014-2999(92)90661-M","volume":"210","author":"NE Rhaleb","year":"1992","unstructured":"Rhaleb NE, Rouissi N, Jukic D et al (1992) Pharmacological characterization of a new highly potent B2 receptor antagonist (HOE 140: D-Arg-[Hyp3, Thi5, D-Tic7, Qic8] bradykinin). Eur J Pharmacol 210:115\u2013120","journal-title":"Eur J Pharmacol"},{"issue":"3","key":"8553_CR157","doi-asserted-by":"publisher","first-page":"774","DOI":"10.1111\/j.1476-5381.1991.tb12249.x","volume":"102","author":"K Wirth","year":"1991","unstructured":"Wirth K, Hock FJ, Albus U et al (1991) Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies. Br J Pharmacol 102(3):774\u2013777","journal-title":"Br J Pharmacol"},{"key":"8553_CR158","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1111\/j.1365-2125.1994.tb04360.x","volume":"38","author":"JR Cockcroft","year":"1994","unstructured":"Cockcroft JR, Chowienczyk PJ, Brett SE, Bender N, Ritter JM (1994) Inhibition of bradykinin-induced vasodilation in human forearm vasculature by icatibant, a potent B2-receptor antagonist. Br J Clin Pharmacol 38:317\u2013321","journal-title":"Br J Clin Pharmacol"},{"key":"8553_CR159","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1016\/j.jaci.2007.02.012","volume":"119","author":"K Bork","year":"2007","unstructured":"Bork K, Frank J, Grundt B, Schlattmann P, Nussberger J, Kreuz W (2007) Treatment of acute edema attacks in hereditary angioedema with a bradykinin receptor-2 antagonist (icatibant). J Allergy Clin Immunol 119:1497\u20131503","journal-title":"J Allergy Clin Immunol"},{"key":"8553_CR160","doi-asserted-by":"publisher","first-page":"532","DOI":"10.1056\/NEJMoa0906393","volume":"363","author":"M Cicardi","year":"2010","unstructured":"Cicardi M, Banerji A, Bracho F, Malbr\u00e1n A, Rosenkranz B et al (2010) Icatibant, a new bradykinin-receptor antagonist, in hereditary angioedema. N Engl J Med 363:532\u2013541","journal-title":"N Engl J Med"},{"issue":"6","key":"8553_CR161","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/j.anai.2011.08.015","volume":"107","author":"WR Lumry","year":"2011","unstructured":"Lumry WR, Li HH, Levy RJ et al (2011) Randomized placebo-controlled trial of the bradykinin B2 receptor antagonist icatibant for the treatment of acute attacks of hereditary angioedema: the FAST-3 trial. Ann Allergy Asthma Immunol 107(6):529\u2013537","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"6","key":"8553_CR162","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1111\/trf.12501","volume":"54","author":"I Martinez-Saguer","year":"2014","unstructured":"Martinez-Saguer I, Cicardi M, Suffritti C, Rusicke E, Ayg\u00f6ren-P\u00fcrs\u00fcn E et al (2014) Pharmacokinetics of plasma-derived C1-esterase inhibitor after subcutaneous versus intravenous administration in subjects with mild or moderate hereditary angioedema: the PASSION Study. Transfusion 54(6):1552\u20131561","journal-title":"Transfusion"},{"key":"8553_CR163","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1111\/all.12658","volume":"70","author":"BL Zuraw","year":"2015","unstructured":"Zuraw BL, Cicardi M, Longhurst HJ, Bernstein JA, Li HH, Magerl M et al (2015) Phase II study results of a replacement therapy for hereditary angioedema with subcutaneous C1-inhibitor concentrate. Allergy 70:1319\u20131328","journal-title":"Allergy"},{"issue":"2, Suppl","key":"8553_CR164","doi-asserted-by":"publisher","first-page":"AB278","DOI":"10.1016\/j.jaci.2014.12.1849","volume":"135","author":"MA Riedl","year":"2015","unstructured":"Riedl MA, Lumry WR, Li HH, Banerji A, Bernstein JA et al (2015) Subcutaneous human C1-inhibitor with recombinant human hyaluronidase for the prevention of angioedema attacks in patients with hereditary angioedema: results of a randomized, double-blind, dose-ranging, crossover study. J All Clin Immunol 135(2, Suppl):AB278 (#904)","journal-title":"J All Clin Immunol"},{"issue":"2, Suppl","key":"8553_CR165","doi-asserted-by":"publisher","first-page":"AB32","DOI":"10.1016\/j.jaci.2012.12.795","volume":"131","author":"D Sexton","year":"2013","unstructured":"Sexton D, Faucette R, Viswanathan M et al (2013) Discovery and characterization of a fully human monoclonal antibody inhibitor of plasma kallikrein for the treatment of plasma kallikrein-mediated edema. J Allergy Clin Immunol 131(2, Suppl):AB32\u2013AB116","journal-title":"J Allergy Clin Immunol"},{"key":"8553_CR166","unstructured":"https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01984788. Accessed 25 Dec 2015"},{"issue":"19","key":"8553_CR167","doi-asserted-by":"publisher","first-page":"5302","DOI":"10.1182\/blood-2011-05-355248","volume":"118","author":"AS Revenko","year":"2011","unstructured":"Revenko AS, Gao D, Crosby JR, Bhattacharjee G, Zhao C et al (2011) Selective depletion of plasma prekallikrein or coagulation factor XII inhibits thrombosis in mice without increased risk of bleeding. Blood 118(19):5302\u20135311","journal-title":"Blood"},{"issue":"222","key":"8553_CR168","doi-asserted-by":"publisher","first-page":"222ra7","DOI":"10.1126\/scitranslmed.3006804","volume":"6","author":"M Larsson","year":"2014","unstructured":"Larsson M, Rayzman V, Nolte MW et al (2014) A factor XIIa inhibitory antibody provides thromboprotection in extracorporeal circulation without increasing bleeding risk. Sci Transl Med 6(222):222ra7","journal-title":"Sci Transl Med"},{"issue":"17","key":"8553_CR169","doi-asserted-by":"publisher","first-page":"247","DOI":"10.3978\/j.issn.2305-5839.2015.09.07","volume":"3","author":"M Worm","year":"2015","unstructured":"Worm M, K\u00f6hler EC, Panda R, Long A, Lynn M, Butler LM et al (2015) The factor XIIa blocking antibody 3F7: a safe anticoagulant with anti-inflammatory activities. Ann Transl Med 3(17):247. doi:10.3978\/j.issn.2305-5839.2015.09.07","journal-title":"Ann Transl Med"},{"key":"8553_CR170","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1136\/jcp.55.2.145","volume":"55","author":"MM Gompels","year":"2002","unstructured":"Gompels MM, Lock RJ, Gid\u00f3falvy E, F\u00fcst G, Varga L (2002) A multicentre evaluation of the diagnostic efficiency of serological investigations for C1 inhibitor deficiency. J Clin Pathol 55:145\u2013147","journal-title":"J Clin Pathol"},{"issue":"3","key":"8553_CR171","doi-asserted-by":"publisher","first-page":"205","DOI":"10.1016\/j.transci.2003.08.009","volume":"29","author":"T Bowen","year":"2003","unstructured":"Bowen T, Hebert J, Ritchie B, Burnhama J, MacSween M, Warrington R et al (2003) Management of hereditary angioedema: a Canadian approach. Transfus Apher Sci 29(3):205\u2013214","journal-title":"Transfus Apher Sci"},{"issue":"suppl 3","key":"8553_CR172","doi-asserted-by":"publisher","first-page":"S51","DOI":"10.1016\/j.jaci.2004.06.047","volume":"114","author":"A Agostoni","year":"2004","unstructured":"Agostoni A, Aygoren-Pursun E, Binkley KE, Blanch A, Bork K, Bouillet L et al (2004) Hereditary and acquired angioedema: problems and progress: proceedings of the third C1 esterase inhibitor deficiency workshop and beyond. J Allergy Clin Immunol 114(suppl 3):S51\u2013S131","journal-title":"J Allergy Clin Immunol"},{"key":"8553_CR173","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1016\/j.jaci.2004.06.043","volume":"114","author":"T Bowen","year":"2004","unstructured":"Bowen T, Cicardi M, Farkas H, Bork K, Kreuz W et al (2004) Canadian 2003 International consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema. J Allergy Clin Immunol 114:629\u2013637","journal-title":"J Allergy Clin Immunol"},{"key":"8553_CR174","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.1365-2249.2005.02726.x","volume":"139","author":"MM Gompels","year":"2005","unstructured":"Gompels MM, Lock RJ, Abinun M, Bethune CA, Davies G, Grattan C et al (2005) C1 inhibitor deficiency: consensus document. Clin Exp Immunol 139:379\u2013394","journal-title":"Clin Exp Immunol"},{"issue":"Suppl 2","key":"8553_CR175","doi-asserted-by":"publisher","first-page":"S30","DOI":"10.1016\/S1081-1206(10)60584-4","volume":"100","author":"T Bowen","year":"2008","unstructured":"Bowen T, Cicardi M, Bork K, Zuraw B, Frank M et al (2008) Hereditary angioedema: a current state-of-the-art review, VII: Canadian Hungarian 2007 International consensus algorithm for the diagnosis, therapy, and management of hereditary angioedema. Ann Allergy Asthma Immunol 100(Suppl 2):S30\u2013S40","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8553_CR176","first-page":"12","volume":"2","author":"A Reshef","year":"2009","unstructured":"Reshef A, Kivity S, Toubi E (2009) Clinical guidelines for the diagnosis and management of hereditary angioedema. Harefuah Update (Allergy Immunol) 2:12\u201320 (Heb)","journal-title":"Harefuah Update (Allergy Immunol)"},{"key":"8553_CR177","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1186\/1710-1492-6-24","volume":"6","author":"T Bowen","year":"2010","unstructured":"Bowen T, Cicardi M, Farkas H, Bork K, Longhurst HJ et al (2010) 2010 International consensus algorithm for the diagnosis, therapy and management of hereditary angioedema. Allergy, Asthma Clin Immunol 6:24","journal-title":"Allergy, Asthma Clin Immunol"},{"key":"8553_CR178","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/1710-1492-6-22","volume":"6","author":"HJ Longhurst","year":"2010","unstructured":"Longhurst HJ, Farkas H, Craig T, Ayg\u00f6ren-P\u00fcrs\u00fcn E, Bethune C et al (2010) HAE international home therapy consensus document. Allergy, Asthma Clin Immunol 6:22","journal-title":"Allergy, Asthma Clin Immunol"},{"key":"8553_CR179","first-page":"333","volume":"21","author":"T Caballero","year":"2011","unstructured":"Caballero T, Baeza ML, Caba\u00f1as R, Campos A, Cimbollek S et al (2011) Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part I. Classification, epidemiology, pathophysiology, genetics, clinical symptoms, and diagnosis. J Investig Allergol Clin Immunol 21:333\u2013347","journal-title":"J Investig Allergol Clin Immunol"},{"key":"8553_CR180","first-page":"422","volume":"21","author":"T Caballero","year":"2011","unstructured":"Caballero T, Baeza ML, Caba\u00f1as R, Campos A, Cimbollek S et al (2011) Consensus statement on the diagnosis, management, and treatment of angioedema mediated by bradykinin. Part II. Treatment, follow-up, and special situations. J Investig Allergol Clin Immunol 21:422\u2013441","journal-title":"J Investig Allergol Clin Immunol"},{"key":"8553_CR181","unstructured":"Bork K, Maurer M, Bas M, Hartmann K, Biederman T et al. (2011) German guidelines for hereditary angioedema due to C1-INH deficiency. Available from www.angioedema.de\/englisch\/infos.htm. Accessed 25 Dec 2015"},{"key":"8553_CR182","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1111\/j.1398-9995.2011.02751.x","volume":"67","author":"M Cicardi","year":"2012","unstructured":"Cicardi M, Bork K, Caballero T, Craig T, Li HH, Longhurst H, Reshef A, Zuraw B (2012) HAWK (Hereditary Angioedema International Working Group). Evidence based recommendations for the therapeutic management of angioedema owing to hereditary C1 inhibitor deficiency: consensus report of an International Working Group. Allergy 67:147\u2013157","journal-title":"Allergy"},{"key":"8553_CR183","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1097\/WOX.0b013e318279affa","volume":"5","author":"T Craig","year":"2012","unstructured":"Craig T, Ayg\u00f6ren P\u00fcrs\u00fcnn E, Bork K, Bowen T, Boysen H et al (2012) WAO guideline for the management of hereditary angioedema. World Allergy Organ J 5:182\u2013199","journal-title":"World Allergy Organ J"},{"key":"8553_CR184","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1016\/j.jaci.2011.11.025","volume":"129","author":"T Caballero","year":"2012","unstructured":"Caballero T, Farkas H, Bouillet L, Bowen T, Gompel A et al (2012) International consensus and practical guidelines on the gynecologic and obstetric management of female patients with hereditary angioedema caused by C1 inhibitor deficiency. J Allergy Clin Immunol 129:308\u2013320","journal-title":"J Allergy Clin Immunol"},{"key":"8553_CR185","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1007\/s00431-012-1726-4","volume":"171","author":"V Wahn","year":"2012","unstructured":"Wahn V, Aberer W, Eberl W, Fa\u00dfhauer M, K\u00fchne T et al (2012) Hereditary angioedema (HAE) in children and adolescents consensus on therapeutic strategies. Eur J Pediatr 171:1339\u20131348","journal-title":"Eur J Pediatr"},{"issue":"suppl. 1","key":"8553_CR186","doi-asserted-by":"publisher","first-page":"S145","DOI":"10.2500\/aap.2012.33.3627","volume":"33","author":"BL Zuraw","year":"2012","unstructured":"Zuraw BL, Bork K, Binkley KE et al (2012) Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel. Allergy Asthma Proc 33(suppl 1):S145\u2013S156","journal-title":"Allergy Asthma Proc"},{"key":"8553_CR187","doi-asserted-by":"publisher","first-page":"1491","DOI":"10.1016\/j.jaci.2013.03.034","volume":"131","author":"BL Zuraw","year":"2013","unstructured":"Zuraw BL, Bernstein JA, Lang DM (2013) A focused parameter update: hereditary angioedema, acquired C1 inhibitor deficiency, and angiotensin-converting enzyme inhibitor-associated angioedema. J Allergy Clin Immunol 131:1491\u20131493","journal-title":"J Allergy Clin Immunol"},{"key":"8553_CR188","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jaip.2013.07.002","volume":"1","author":"BL Zuraw","year":"2013","unstructured":"Zuraw BL, Banerji A, Bernstein JA, Busse PJ, Christiansen SC et al (2013) US Hereditary Angioedema Association Medical Advisory Board 2013 Recommendations for the management of hereditary angioedema due to C1 inhibitor deficiency. J Allergy Clin Immunol Pract 1:458\u2013467","journal-title":"J Allergy Clin Immunol Pract"},{"key":"8553_CR189","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1097\/MEJ.0b013e328356f76e","volume":"20","author":"T Jaiganesh","year":"2013","unstructured":"Jaiganesh T, Wiese M, Hollingsworth J, Hughan C, Kamara M, Wood P, Bethune C (2013) Acute angioedema: recognition and management in the emergency department. Eur J Emerg Med 20:10\u201317","journal-title":"Eur J Emerg Med"},{"key":"8553_CR190","doi-asserted-by":"publisher","first-page":"602","DOI":"10.1111\/all.12380","volume":"69","author":"M Cicardi","year":"2014","unstructured":"Cicardi M, Aberer W, Banerji A et al (2014) Classification, diagnosis, and approach to treatment for angioedema: consensus report from the Hereditary Angioedema International Working Group. Allergy 69:602\u2013616","journal-title":"Allergy"},{"key":"8553_CR191","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1186\/1710-1492-10-50","volume":"10","author":"S Betschel","year":"2014","unstructured":"Betschel S, Badiou J, Binkley K, H\u00e9bert J, Kanani A et al (2014) Canadian hereditary angioedema guideline. Allergy, Asthma Clin Immunol 10:50","journal-title":"Allergy, Asthma Clin Immunol"},{"issue":"4","key":"8553_CR192","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1111\/acem.12341","volume":"21","author":"JJ Moellman","year":"2014","unstructured":"Moellman JJ, Bernstein JA, Lindsell C (2014) A consensus parameter for the evaluation and management of angioedema in the emergency department. Acad Emerg Med 21(4):469\u2013484","journal-title":"Acad Emerg Med"},{"key":"8553_CR193","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s11739-013-0993-z","volume":"9","author":"M Cicardi","year":"2014","unstructured":"Cicardi M, Bellis P, Bertazzoni G, Cancian M, Chiesa M, Cremonesi P et al (2014) Guidance for diagnosis and treatment of acute angioedema in the emergency department: consensus statement by a panel of Italian experts. Intern Emerg Med 9:85\u201392","journal-title":"Intern Emerg Med"},{"key":"8553_CR194","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1111\/cei.12584","volume":"180","author":"HJ Longhurst","year":"2015","unstructured":"Longhurst HJ, Tarzi MD, Ashworth F, Bethune C, Cale C, Dempster J, Gompels M et al (2015) C1 inhibitor deficiency: 2014 United Kingdom consensus document. Clin Exp Immunol 180:475\u2013483","journal-title":"Clin Exp Immunol"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-016-8553-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12016-016-8553-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-016-8553-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T13:53:24Z","timestamp":1718632404000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12016-016-8553-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,6,10]]},"references-count":194,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["8553"],"URL":"https:\/\/doi.org\/10.1007\/s12016-016-8553-8","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,6,10]]},"assertion":[{"value":"10 June 2016","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}